// App-Quantinova.ai

TPS9657 : POWER-remote: A randomized study evaluating the effect of a remote-based weight loss program on biomarkers in women with early-stage breast cancer.

Researchers

Presenter

  • Cesar Augusto Santa-Maria

Principal Investigators

  • Amanda Blackford

  • Gerald J Jerome

  • Arlene Dalcin

  • Christina Shehata

  • Stacie Jeter

  • Colleen Schreyer

  • Brandon Luber

  • Lawrence J Appel

  • Vered Stearns

  • Janelle Coughlin

  • Claire Frances Snyder

Medical Centers

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MDThe Johns Hopkins Hospital and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MDThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

  • Towson University, Baltimore, MD

  • Johns Hopkins University School of Medicine, Baltimore, MDThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Obesity

  • Solid malignancies

Biomarkers

  • High sensitivity C-reactive protein

  • Insulin-like growth factor 1

  • Interleukin 1

  • Interleukin 6

  • Tumor necrosis factor

  • Body mass index

Drug/Treatment

  • Zoledronic acid

  • Alora

  • Digoxin

  • Mecasermin

Outcome

  • Unknown

Study Design

  • randomized

Phase

  • NA

Study Id's

  • NCT01871116

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved